Over the past year, many Abbott Laboratories (NYSE:ABT) insiders sold a significant stake in the company which may have piqued investors' interest. When evaluating insider transactions ...

Aristotle Atlantic Core Equity Strategy stated the following regarding Abbott Laboratories (NYSE:ABT) in its Q2 2024 investor letter: "We sold Abbott Laboratories (NYSE:ABT) given the full ...

Over the past year, many Abbott Laboratories (NYSE:ABT) insiders sold a significant stake in the company which may have piqued investors' interest. When analyzing insider transactions, it is usually ...

R obert B. Ford (NYSE:F), Chairman and CEO of Abbott Laboratories (NYSE:ABT), recently sold a significant portion of his holdings in the company. According to a Form 4 filing with the Securities ...

Adria Cimino has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Abbott Laboratories. The Motley Fool has a disclosure policy.

Abbott Laboratories insiders didn't buy any shares over the last year. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you want ...